Demand for human leukocyte antigen or human platelet antigen‐selected platelets: An observational study at Canadian Blood Services
The CBS HLA/HPA Platelet Program has experienced a rise in product demand. The strong relationship between product requests and issuance demonstrates the responsiveness of this program, though variability in fill rates and the limited predictive value of case counts highlight ongoing operational challenges. These findings can inform strategies for donor recruitment, inventory management, and case management to ensure reliable access to compatible platelets for sensitized patients.
Authors
- Matthew D. Seftel (ORCID: https://orcid.org/0000-0002-0960-2687)
- John T. Blake (ORCID: https://orcid.org/0000-0003-0617-8996)
- Johnathan Mack (ORCID: https://orcid.org/0000-0002-8304-1953)
- Natasha Rickards
- Akash Gupta (ORCID: https://orcid.org/0000-0001-6838-2576)
- P. Le Hoang (ORCID: https://orcid.org/0009-0008-1426-0627)
Institutions
- Dalhousie University (CA)
- University of British Columbia (CA)
- University of Toronto (CA)
- Ottawa Hospital (CA)
- McGill University Health Centre (CA)
- Ottawa Hospital Research Institute (CA)
- McGill University (CA)
- Canadian Blood Services (CA)
Publication Details
- Journal
- Transfusion
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1111/trf.70025
- Primary Topic
- Blood donation and transfusion practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00